Chandrasekhar Rao Jadcherla has filed to sell 6,000 shares of EGAIN Corporation, with an aggregate market value of approximately $35,421. This filing, submitted on November 2, 2026, indicates ongoing stock option exercises by the officer of the company.

EGAIN Corporation, incorporated in Delaware, operates in the services-prepackaged software sector. The company is listed under the SEC file number 001-35314 and is located at 1252 Borregas Avenue, Sunnyvale, CA.

The filing states, "Chandrasekhar J Rao has acquired 6,000 shares through a stock option exercise on the same date as the filing." This transaction is part of a series of sales and exercises by Rao, who previously sold 6,000 shares on October 1, 2026, for gross proceeds of $35,261.40, and another 6,000 shares on September 15, 2026, for $30,921.00.

This activity may affect shareholders and potential investors, as it reflects the confidence of company executives in EGAIN's future performance. The prepackaged software industry continues to observe such executive transactions closely, as they can influence market perceptions and stock valuations.

The filing does not say what happens next.

Additional Details from the Filing

The filing indicates that the shares being sold by Chandrasekhar Rao Jadcherla were acquired through a stock option exercise on the same date as the filing, November 2, 2026. This acquisition involved a cash payment, and the shares are classified as common stock. The total number of shares outstanding for EGAIN Corporation is reported to be 26,171,467.

Furthermore, the filing specifies that the broker handling this transaction is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY.

It is also noteworthy that this is not the first time Rao has engaged in such transactions; he sold 6,000 shares on October 1, 2026, and another 6,000 shares on September 15, 2026. The gross proceeds from these prior sales were $35,261.40 and $30,921.00, respectively.

The filing does not include any forward-looking statements or projections regarding the company's performance or the potential impact of these transactions on the stock price.